Lv1
80 积分 2023-07-09 加入
Redefining the Limits of Highly Conformal Radiation Therapy for Brain Metastases
14天前
已完结
Disease Kinetics and Practice Patterns in ≥4-Year Long-Term Beneficiaries of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer
15天前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
28天前
已完结
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases
3个月前
已完结
Beyond single-target ADCs: are bispecific conjugates the next step in EGFR-mutated NSCLC?
3个月前
已关闭
Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab
3个月前
已关闭
NSCLC: Five trials to watch
3个月前
已完结
Checkpoint Breaches: Unexpected Effects of Anti–PD-1 Therapy on the Blood–Brain Barrier
3个月前
已完结
Enhancing Immune Cell Trafficking to Brain Tumors: Recent Advances and Therapeutic Strategies
3个月前
已完结
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy
3个月前
已完结
皖公网安备34019202002308
